These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16867223)
1. In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. Hama Y; Urano Y; Koyama Y; Kamiya M; Bernardo M; Paik RS; Krishna MC; Choyke PL; Kobayashi H Neoplasia; 2006 Jul; 8(7):607-12. PubMed ID: 16867223 [TBL] [Abstract][Full Text] [Related]
2. A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a "smart" fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases. Hama Y; Urano Y; Koyama Y; Gunn AJ; Choyke PL; Kobayashi H Clin Cancer Res; 2007 Nov; 13(21):6335-43. PubMed ID: 17975145 [TBL] [Abstract][Full Text] [Related]
3. D-galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine green. Hama Y; Urano Y; Koyama Y; Choyke PL; Kobayashi H J Biomed Opt; 2007; 12(5):051501. PubMed ID: 17994865 [TBL] [Abstract][Full Text] [Related]
4. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Hama Y; Urano Y; Koyama Y; Choyke PL; Kobayashi H Biochem Biophys Res Commun; 2006 Sep; 348(3):807-13. PubMed ID: 16904640 [TBL] [Abstract][Full Text] [Related]
5. Galactosyl human serum albumin-NMP1 conjugate: a near infrared (NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases. Alexander VM; Sano K; Yu Z; Nakajima T; Choyke PL; Ptaszek M; Kobayashi H Bioconjug Chem; 2012 Aug; 23(8):1671-9. PubMed ID: 22799539 [TBL] [Abstract][Full Text] [Related]
6. Highly sensitive fluorescence imaging of cancer with avidin-protease probe conjugate. Yamamoto K; Kamiya M; Urano Y Bioorg Med Chem Lett; 2019 Oct; 29(20):126663. PubMed ID: 31521477 [TBL] [Abstract][Full Text] [Related]
7. Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. Hama Y; Urano Y; Koyama Y; Choyke PL; Kobayashi H Cancer Res; 2007 Apr; 67(8):3809-17. PubMed ID: 17440095 [TBL] [Abstract][Full Text] [Related]
8. A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Hama Y; Urano Y; Koyama Y; Kamiya M; Bernardo M; Paik RS; Shin IS; Paik CH; Choyke PL; Kobayashi H Cancer Res; 2007 Mar; 67(6):2791-9. PubMed ID: 17363601 [TBL] [Abstract][Full Text] [Related]
9. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore. Gunn AJ; Hama Y; Koyama Y; Kohn EC; Choyke PL; Kobayashi H Cancer Sci; 2007 Nov; 98(11):1727-33. PubMed ID: 17784874 [TBL] [Abstract][Full Text] [Related]
10. Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Kosaka N; Mitsunaga M; Longmire MR; Choyke PL; Kobayashi H Int J Cancer; 2011 Oct; 129(7):1671-7. PubMed ID: 21469142 [TBL] [Abstract][Full Text] [Related]
11. Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe. Nakamura Y; Harada T; Nagaya T; Sato K; Okuyama S; Choyke PL; Kobayashi H Oncotarget; 2016 Aug; 7(32):51124-51137. PubMed ID: 27286461 [TBL] [Abstract][Full Text] [Related]
12. Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo. Asanuma D; Sakabe M; Kamiya M; Yamamoto K; Hiratake J; Ogawa M; Kosaka N; Choyke PL; Nagano T; Kobayashi H; Urano Y Nat Commun; 2015 Mar; 6():6463. PubMed ID: 25765713 [TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins. Fujii T; Kamiya M; Urano Y Bioconjug Chem; 2014 Oct; 25(10):1838-46. PubMed ID: 25196809 [TBL] [Abstract][Full Text] [Related]
15. In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model. Hornung R; Major AL; McHale M; Liaw LH; Sabiniano LA; Tromberg BJ; Berns MW; Tadir Y J Am Assoc Gynecol Laparosc; 1998 May; 5(2):141-8. PubMed ID: 9564061 [TBL] [Abstract][Full Text] [Related]
16. Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer. Cocco E; Shapiro EM; Gasparrini S; Lopez S; Schwab CL; Bellone S; Bortolomai I; Sumi NJ; Bonazzoli E; Nicoletti R; Deng Y; Saltzman WM; Zeiss CJ; Centritto F; Black JD; Silasi DA; Ratner E; Azodi M; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD Int J Cancer; 2015 Dec; 137(11):2618-29. PubMed ID: 26060989 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells. Hama Y; Urano Y; Koyama Y; Bernardo M; Choyke PL; Kobayashi H Bioconjug Chem; 2006; 17(6):1426-31. PubMed ID: 17105220 [TBL] [Abstract][Full Text] [Related]
18. Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer. Liu S; Zheng Y; Volpi D; El-Kasti M; Klotz D; Tullis I; Henricks A; Campo L; Myers K; Laios A; Thomas P; Ng T; Dhar S; Becker C; Vojnovic B; Ahmed AA Cancer; 2015 Jan; 121(2):202-13. PubMed ID: 25209149 [TBL] [Abstract][Full Text] [Related]
19. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Xu H; Regino CA; Koyama Y; Hama Y; Gunn AJ; Bernardo M; Kobayashi H; Choyke PL; Brechbiel MW Bioconjug Chem; 2007; 18(5):1474-82. PubMed ID: 17711320 [TBL] [Abstract][Full Text] [Related]